Literature DB >> 20558087

Pandemic influenza (H1N1): impact on lung transplant recipients and candidates.

Benjamin Daniel Fox1, Yael Raviv, Dror Rozengarten, Viktoria Rusanov, Ilana Bakal, Mordechai R Kramer.   

Abstract

BACKGROUND: The year 2009 was notable for the outbreak of a novel strain of influenza A (H1N1). We report the outcomes of H1N1 infection in a large cohort of lung transplant (LTx) recipients and candidates.
METHODS: This was a retrospective review of 22 suspected cases of H1N1 influenza screened using real-time polymerase chain reaction from nasal secretions. There were 15 confirmed cases (10 LTx recipients, 5 LTx candidates).
RESULTS: All patients were treated with oseltamivir at the time of the first clinical assessment. In the LTx recipients group, 7 of the 10 confirmed cases were treated at home with oseltamivir alone. Three patients were admitted with complications (2 pneumonia, 1 acute rejection). Two patients required mechanical ventilation. Two patients had prolonged viral shedding. No deaths occurred among the LTx recipients. In the 5 LTx candidates with confirmed H1N1, 2 deaths occurred from pneumonia and acute respiratory distress syndrome.
CONCLUSIONS: Influenza H1N1 had a significant complication rate amongst LTx recipients and a high mortality rate amongst LTx candidates. Copyright 2010 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558087     DOI: 10.1016/j.healun.2010.05.007

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  8 in total

Review 1.  Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients.

Authors:  S Samuel Weigt; Aric L Gregson; Jane C Deng; Joseph P Lynch; John A Belperio
Journal:  Semin Respir Crit Care Med       Date:  2011-08-19       Impact factor: 3.119

2.  An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers.

Authors:  Lukas Kaufmann; Mohammedyaseen Syedbasha; Dominik Vogt; Yvonne Hollenstein; Julia Hartmann; Janina E Linnik; Adrian Egli
Journal:  J Vis Exp       Date:  2017-12-01       Impact factor: 1.355

Review 3.  Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients.

Authors:  Christian Renaud; Angela P Campbell
Journal:  Curr Opin Infect Dis       Date:  2011-08       Impact factor: 4.915

4.  Challenges in the diagnosis of 2009 H1N1 in a lung transplant patient and the long-term implications for prevention and treatment: a case report.

Authors:  C S Davis; C R Deburghgraeve; S Yong; J P Parada; A G Palladino-Davis; E Lowery; J Gagermeier; P M Fisichella
Journal:  Transplant Proc       Date:  2010-12       Impact factor: 1.066

Review 5.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

Review 6.  Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation.

Authors:  Dana J Hawkinson; Michael G Ison
Journal:  Semin Nephrol       Date:  2016-09       Impact factor: 5.299

Review 7.  Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation.

Authors:  Grant C Paulsen; Lara Danziger-Isakov
Journal:  Clin Chest Med       Date:  2017-09-20       Impact factor: 2.878

8.  Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series.

Authors:  Catherine Cohet; François Haguinet; Gaël Dos Santos; Dave Webb; John Logie; Germano Lc Ferreira; Dominique Rosillon; Vivek Shinde
Journal:  BMJ Open       Date:  2016-01-28       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.